ARKG vs LABU overlap - what they share and where they differ
ARKG and LABU share 6.0% of their weight across 12 common positions, read from what each fund reported to the SEC.
Each week Ploutos reads the reported positions of the largest US equity ETFs and measures, pair by pair, the weight they share: for every stock both funds hold, the smaller of the two weights counts. Two funds tracking the same index land near 100%. A sector fund inside a broad index fund lands at roughly that sector's weight.
ARKG and LABU
6.0%
12 shared positions
ARKG
ARK Genomic Revolution ETF
Reported positions cover 100% of the fund, 32 positions · Jul 31, 2026
Top 10: 59.1%·Holdings of ARKG
LABU
Direxion Daily S&P Biotech Bull 3X Shares
Reported positions cover 67% of the fund, 147 positions · Jul 31, 2026
Top 10: 9.4%·Holdings of LABU
Reported positions cover ARKG 100%, LABU 67% of each fund. An overlap cannot exceed the smaller coverage, so a low figure can mean little overlap or thin reporting.
LABU vs ARKG side by side
ARKGARK Genomic Revolution ETF
32
stock positions reported to the SEC
55.6% of its weight is in 20 names LABU does not hold
LABUDirexion Daily S&P Biotech Bull 3X Shares
147
stock positions reported to the SEC
61.1% of its weight is in 135 names ARKG does not hold
Where each fund's weight sits
Largest sectors for both funds
The widest gap is Healthcare: ARKG has 23.1 points more of it.
The figures side by side
| ARKG | LABU | |
|---|---|---|
| Filing date | Jul 31, 2026 | Jul 31, 2026 |
| Stock positions reported | 32 | 147 |
| Weight of the ten largest | 59.1% | 9.4% |
| Largest position | TXG 9.4% | APOGEE THERAPEUTICS INC 1.1% |
| Held alone | 20 positions, 55.6% | 135 positions, 61.1% |
| Covered by stock positions | 100% | 67% |
Holdings they share
| Stock | In ARKG | In LABU | Counted |
|---|---|---|---|
| TWSTTWIST BIOSCIENCE CORP | 7.73% | 0.92% | 0.92% |
| NTRANATERA INC | 4.13% | 0.84% | 0.84% |
| CRSPCRISPR THERAPEUTICS AG | 6.29% | 0.66% | 0.66% |
| BEAMBEAM THERAPEUTICS INC | 3.78% | 0.59% | 0.59% |
| IONSIONIS PHARMACEUTICALS INC | 1.77% | 0.48% | 0.48% |
| VCYTVERACYTE INC | 2.55% | 0.48% | 0.48% |
| RXRXRECURSION PHARMACEUTICALS INC | 2.63% | 0.46% | 0.46% |
| NTLAINTELLIA THERAPEUTICS INC | 1.83% | 0.42% | 0.42% |
| NRIXNURIX THERAPEUTICS INC | 2.51% | 0.39% | 0.39% |
| CDNACAREDX INC | 4.30% | 0.34% | 0.34% |
What each holds alone
The heaviest positions one fund reports and the other does not.
Only in ARKG
Only in LABU
Questions people ask
Is ARKG the same as LABU?
6.0% of their weight sits in the same 12 holdings. ARKG also reports TXG, TEM, PSNL, which the other does not. LABU also reports APOGEE THERAPEUTICS INC, ORKA, DNTH, which the other does not.
How is the overlap between ARKG and LABU measured?
For every stock both funds report, the smaller of the two weights counts, and the sum is the overlap. The reported positions cover 100% of ARKG and 67% of LABU, so the number cannot exceed the smaller coverage.
Which holds more, LABU or ARKG?
ARKG reports 32 stock positions and LABU reports 147. 55.6% of ARKG's weight sits in names LABU does not hold, and 61.1% of LABU's weight in names ARKG does not hold. The ten largest positions are 59.1% of ARKG and 9.4% of LABU.
How do ARKG and LABU differ by sector?
The widest gap is Healthcare: ARKG has 23.1 points more of it. Sectors come from each holding's SIC code in its SEC record, summed by the weight the fund reports.
Where do the numbers come from?
From each fund's own N-PORT filing to the SEC, which lists every position and its weight. The comparison uses every equity position the fund reports; cash, futures and bonds are not counted, which is why a coverage figure sits next to every result. Holdings change between filings.
Add a third fund in the tool·All fund pairs
Descriptive data from public SEC filings. Nothing on this page is a recommendation to buy, sell or hold any fund or stock, and holdings change between filings.